Bayer (China): a leading multinational pharma company in China with leadership in China’s key therapeutic areas such as Diabetes, Cardiovascular, Anti-infectious, Oncology, Women’s Health, etc.
Targovax: a clinical-stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors.
Celsion: a fully-integrated oncology company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies, immunotherapies, and RNA- or DNA-based therapies.
Denovo Biopharma: a clinical-stage biopharmaceutical company that applies novel biomarker approaches to re-evaluate medicines that have failed in broad patient populations.
Cerenetex is the leading company focused specifically on the science, development, and commercialization of acoustic-based technologies for the non-invasive detection of neuropathologies.
Dyadic is a global biotechnology company focused on further improving and leveraging the patented and proprietary C1 expression system to help bring biologic vaccines and drugs to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers to improve access and cost to patients and the healthcare system.
Virometix is a Swiss biotechnology company developing next-generation synthetic vaccines to prevent infectious diseases and treat chronic diseases.
OncoGenesis brings to the marketplace iPap™, a patented sample self-collection device coupled with CerMark™ Point-of-Care and LAB systems that detects persistent high-risk HPV infections (the cause of cervical disease) as well as evidence and prognostic risk of precancerous lesions.
Gero is a biotech company using a proprietary next-generation AI platform for big biomedical data analysis to discover therapeutics targeting aging.
Click here to see the complete company summary. 10 more companies to be announced, please stay tuned.
- 10 minutes presentation
- Exclusive Partnering Consultation
- Immediate Ad-Hoc Meetings
- Post-event follow-ups
And pitch their company directly to these renowned investors:
· 6 Dimensions Capital · Boehringer Ingelheim · Buchang Pharma · CDIB Capital · CICC · CITIC Securities Investment · Convergence Partners · Cowin venture · Crosswave Management · Fosun pharma · Guoqian VC · Haisco Pharmaceutical Ltd · Hengrui Medicine · SDIC FUND Management Co. Ltd. · Shenzhen Royal Capital · Shuoyou investment · Silicon Valley Bank · Velocity Partners · VI Ventures · Viva BioInnovator · WinnerMax Capital · Wu Capital · YUANMING CAPITAL
Last 3 slots available! If you are interested in presenting to these potential partners like our participating companies, get in on the action! Secure the most efficient approach to propel your China Strategies.